Pacific Biosciences Of California (PACB) Change in Inventory (2011 - 2026)

Pacific Biosciences Of California has reported Change in Inventory for 16 years, with the latest figure at $3.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 26.32% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (up 361.86% YoY), and the FY2025 full-year result was $1.4 million, down 82.94% from the prior year.
• Change in Inventory for Q1 2026 stood at $3.2 million, up from -$3.5 million in the prior quarter.
• The five-year high for Change in Inventory was $13.3 million in Q1 2023, with the low at -$9.0 million in Q4 2023.
• Average Change in Inventory over 5 years is $3.6 million, with a median of $3.2 million recorded in 2026.
• Year-over-year, Change in Inventory soared 235.25% in 2022 and plunged 185.47% in 2023.
• Tracing PACB's Change in Inventory over 5 years: stood at $10.5 million in 2022, then sank by 185.47% to -$9.0 million in 2023, then rose by 21.47% to -$7.1 million in 2024, then soared by 50.42% to -$3.5 million in 2025, then surged by 191.42% to $3.2 million in 2026.
• The last three Change in Inventory figures came in at $3.2 million (Q1 2026), -$3.5 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison